All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
Erlotirel 150mg Tablet
Prescription Required
Salt Composition : Erlotinib
Manufacturer : RELIANCE LIFE SCIENCES PVT LTD
Origin of Medicine : India
30 Tablet(s) In A Bottle
Introduction to Erlotirel 150mg Tablet
Erlotirel 150mg Tablet is an anticancer medicine containing active constituent erlotinib. It is used to treat non-small lung cancer (NSCLC) and pancreatic cancer. Cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner. It is usually given in combination with other anticancer medicine, gemcitabine, for patients with metastatic or advanced pancreatic cancers.
Inform the doctor if you use contact lenses, have an intolerance to sugars, history of eye problems, or if any medicines taken for clotting disorders or cholesterol. This medication can cause eye dryness and conjunctivitis and hence patients are advised to inform the history of vision problems, use of contact lenses before taking this medication. Erlotirel 150mg Tablet is not recommended for adolescents and children under the age of 18. Do not take this medication with food. Use effective birth control during the treatment and for at least 2 weeks after the last dose.
Patients are advised not to smoke while being treated with Erlotirel 150mg Tablet, as smoking may decrease the amount of medicine in the blood. Wear protective clothing and sunscreen while going outside. Inform the physician if the patient has any symptoms like pain in the eye, blurred vision, cough, fever, shortness of breath, severe abdominal pain, and persistent diarrhea while taking this medicine.
Uses of Erlotirel 150mg Tablet
- Advanced or metastatic non-small lung cancer (NSCLC)
- Advanced or metastatic pancreatic cancer
Therapeutic Effects of Erlotirel 150mg Tablet
Erlotirel 150mg Tablet prevents the activity of a protein called epidermal growth factor receptor (EFGR), a protein involved in the spread and growth of cancer cells.
Interaction of Erlotirel 150mg Tablet with other drugs
Inform the doctor about any medications you are taking or have taken before the treatment
More Information about Erlotirel 150mg Tablet
- Keep out of sight and reach of children.
- Store at controlled room temperature between 15°C to 30°C.
- Do not freeze.
How to consume Erlotirel 150mg Tablet
Always take this medicine as prescribed by the doctor. The tablet must be taken at least one hour before or two hours after taking food.
Safety Advices for Erlotirel 150mg Tablet
Pregnancy
Taking Erlotirel 150mg Tablet while pregnant can harm the baby. Do not take this medicine during pregnancy unless your doctor recommends taking it. Inform your doctor if you are pregnant or planning to be pregnant before taking this medicine.
Breast Feeding
Do not take Erlotirel 150mg Tablet if you are breastfeeding. Consult the doctor for risks and benefits.
Lungs
This medicine is not recommended in patients with severe lung diseases. Inform the physician if you have any lung disorders.
Liver
This medicine is not recommended in patients with severe liver diseases. Inform the physician about any liver disorders.
Alcohol
Avoid consuming alcohol while taking Erlotirel 100mg Tablet. Alcohol may increase the risk of side effects such as dizziness or liver complications. Consult your doctor before consuming alcohol during your treatment.
Driving
Erlotirel 100mg Tablet may cause side effects like dizziness, drowsiness, or blurred vision, which can affect your ability to drive or operate machinery. Do not drive or engage in activities that require alertness until you know how this medicine affects you.
Side Effects of Erlotirel 150mg Tablet
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious:
- Persistent or severe diarrhea
- Pain in the eye, blurred vision
- Sudden difficulty in breathing accompanied by cough and fever
- Severe pain in your abdomen
- Liver failure
Common:
- Rash, worsened in sun-exposed areas
- Loss of appetite, decreased weight
- Infection
- Headache
- Depression
- Nausea
- Mouth irritation
- Indigestion
- Hair loss, dry skin, itching, acne, cracked skin
- Tiredness
- Inflammation around fingernail
- Bleeding from nose, stomach, intestines
- Reduced kidney function
Word of Advice
Inform the doctor if you have vision problems, are using contact lenses, clotting disorders, intolerance to sugar and taking any medication for cholesterol before starting this medication. This medication should not be taken along with the food and it can be taken either before or after food as it increases the effectiveness of the medication. It is not recommended for individuals below 18 years of age. Inform the doctor about kidney, liver disorders as this medication is not recommended in the patient’s with kidney and liver disorders. Avoid making plans to have children or during pregnancy because this medicine is highly unsafe and causes harmful effects on the developing baby.
FAQs
Q 1. How should I take Erlotirel 150mg Tablet?
Always take this medicine as prescribed by the doctor. The tablet must be taken at least one hour before or two hours after taking food, and it should be taken at a fixed time daily.
Q 2. Does Erlotirel 150mg Tablet cause eye dryness?
Yes, this medication can cause eye dryness and conjunctivitis, and hence, patients are advised to inform their history of vision problems and use contact lenses before taking this medication.
Q 3. Can I smoke while taking Erlotirel 150mg Tablet?
Avoid smoking while taking this medication as it can decrease the effectiveness of this medication.
Q 4. How long can I take Erlotirel 150mg Tablet?
Erlotirel 150mg Tablet is taken daily as long as prescribed by the doctor and duration of time varies from patient to patient depending upon the severity of the disease
Fact Box of Erlotirel 150mg Tablet
Molecule name: Erlotinib
| Therapeutic class: Tyrosine kinase inhibitor |
Pharmacological class: Anti-Neoplastics | Indications: 1. Advanced or metastatic non-small lung cancer (NSCLC) 2. Advanced or metastatic pancreatic cancer |
References
- Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines, 12th edition, 2011, 1735-1737.
- Mylan, Electronic medicines compendium (emc), [ Revised on Jan 2020] [ Accessed on 14th April 2021], https://www.medicines.org.uk/emc/files/pil.11264.pdf
- Genentech, US Food and Drug Administration, [ Revised on April 2010] [ Accessed on 14th April 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021743s14s16lbl.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
